BOSTON----Salix Pharmaceuticals, Ltd. today announces that the 60th Annual Meeting of the American Association for the Study of Liver Diseases is the venue for two presentations describing the investigation of rifaximin for the... [read full story]
|
RELATED
|
|
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP - A live webcast of the event will be available on the Company’s website at www.Salix.com. Carolyn Logan, President and CEO, Salix, will host the session...
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP - News) today announced that the Company will present at the 2009 Credit Suisse Healthcare Conference in Phoenix, AZ on Wednesday, November 11 at 3:30...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will host an Analyst Day on Wednesday, November 18, 2009 from 10:00 a.m. to 12:00 noon Eastern Time. A live webcast of the event will be available on...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will host an Analyst Day on Wednesday, November 18, 2009 from 10:00 a.m. to 12:00 noon Eastern Time. A live webcast of the event will be available on...
RALEIGH, N.C. - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will host an Analyst Day on Wednesday, November 18, 2009 from 10:00 a.m. to 12:00 noon Eastern Time. A live webcast of the event will be...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will host an Analyst Day on Wednesday, November 18, 2009 from 10:00 a.m. to 12:00 noon Eastern Time. A live webcast of the event will be available on...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the 2009 Credit Suisse Healthcare Conference in Phoenix, AZ on Wednesday, November 11 at 3:30 p.m. MT/5:30 p.m. ET. Interested parties...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the 2009 Credit Suisse Healthcare Conference in Phoenix, AZ on Wednesday, November 11 at 3:30 p.m. MT/5:30 p.m. ET.
RALEIGH, N.C. - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the 2009 Credit Suisse Healthcare Conference in Phoenix, AZ on Wednesday, November 11 at 3:30 p.m. MT/5:30 p.m. ET....
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 (the ?199 patent) entitled ?Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin?. The...
